Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Delcath Announces Commercial Licensing Agreement for CHEMOSAT®

pharmafocusasiaDecember 28, 2018

Tag: Delcath , CHEMOSAT® , interventional oncology , liver cancers

PharmaSources Customer Service